Literature DB >> 16971324

Botulinum toxin A treatment for contouring of the lower leg.

Kwang-Ho Han1, Young-Hyun Joo, Sang-Eun Moon, Kyu-Han Kim.   

Abstract

BACKGROUND: Botulinum toxin type A is widely used in the treatment of bilateral masseteric hypertrophy in Asians. Botulinum toxin A may have plausible effects on the oversized calf muscles that cause mental distress in Korean women.
OBJECTIVE: We report our successful use of botulinum toxin A in the treatment of two patients with muscular legs.
METHODS: The toxin was injected into the gastrocnemius muscle, 300-360 U per side.
RESULTS: A reduction in calf circumference was noticed 3 weeks after treatment and was maintained for 6-8 months without systemic side effects.
CONCLUSION: Botulinum toxin treatment for enlarged gastrocnemius muscles is a non-invasive alternative method for the improvement of calf contours.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16971324     DOI: 10.1080/09546630600899070

Source DB:  PubMed          Journal:  J Dermatolog Treat        ISSN: 0954-6634            Impact factor:   3.359


  4 in total

1.  Extra- and intramuscular nerves distributions of the triceps surae muscle as a basis for muscle resection and botulinum toxin injections.

Authors:  V A Sheverdin; M S Hur; S Y Won; W C Song; K S Hu; K S Koh; H J Kim
Journal:  Surg Radiol Anat       Date:  2009-03-20       Impact factor: 1.246

2.  An Update on the Cosmetic Use of Botulinum Toxin: The Pattern of Practice among Korean Dermatologists.

Authors:  Nark-Kyoung Rho; Kwang-Ho Han; Hei-Sung Kim
Journal:  Toxins (Basel)       Date:  2022-05-04       Impact factor: 5.075

3.  Clinical and anatomical approach using Sihler's staining technique (whole mount nerve stain).

Authors:  Sung-Yoon Won; Da-Hye Kim; Hun-Mu Yang; Jong-Tae Park; Hyun-Ho Kwak; Kyung-Seok Hu; Hee-Jin Kim
Journal:  Anat Cell Biol       Date:  2011-03-31

Review 4.  Botulinum Toxin Induced Atrophy: An Uncharted Territory.

Authors:  Mehri Salari; Soumya Sharma; Mandar S Jog
Journal:  Toxins (Basel)       Date:  2018-08-02       Impact factor: 4.546

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.